Lucio Mos

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

P.J. Devereaux, Emmanuelle Duceppe, Gordon Guyatt et al. · The Lancet · 2018 · 325 citations · Full text

Medicine, Cardiology, Surgery +13

CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension

Paolo Palatini, Giulio Ceolotto, Fabio Ragazzo et al. · Journal of Hypertension · 2009 · 225 citations

Medicine, Pharmacology, Biochemical Genetics +16

Target-Organ Damage in Stage I Hypertensive Subjects With White Coat and Sustained Hypertension

Paolo Palatini, Paolo Mormino, Massimo Santonastaso et al. · Hypertension · 1998 · 167 citations

Medicine, Cardiology, Physiology +17